Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 14 May 2024 | 6 May 2024 |
To consider and approve the financial results for the period ended March 31, 2024. Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. (As Per BSE Announcement Dated on: 14/05/2024) | ||
Board Meeting | 7 Nov 2023 | 30 Oct 2023 |
1.To consider and approve the financial results for the period ended September 30, 2023 .2. To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of National Stock Exchange of India Limited & Bombay Stock Exchange of India Limited. Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on November 07, 2023. (As Per NSE Announcement Dated on: 07/11/2023) | ||
Board Meeting | 1 Sep 2023 | 1 Sep 2023 |
Beta Drugs Limited has informed the Exchange regarding Board meeting held on September 01, 2023. |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.